Medical Weight Loss for Medford, Oregon Residents

Medford, Oregon residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Medford through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Start this week from Medford: book a video visit, complete your intake, and if you are a fit, your compounded medication ships to your Oregon door. No travel to California required. Doctor review just $119 (medication separate).

Why Medford Residents Choose New Hope Weight Loss

What draws a lot of Medford patients to New Hope is the honest pricing. Semaglutide starts at $166 a month and tirzepatide at $233 a month, with a $119 physician visit, and that is the whole conversation. There is no surprise line item, no distance surcharge for living outside Costa Mesa, and no pressure to buy a bundle you did not ask for. You see the real numbers before you commit, which is how it should be.

If you are searching for medical weight loss in Medford, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.

If you are searching for a weight-loss physician in Medford, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts Oregon patients exactly where local ones are. We care for patients throughout the greater Medford area and the Rogue Valley of southern Oregon. Your intake, lab review, and dosing are all overseen by a physician, which means real medical supervision behind every package sent to Medford.

By handling visits through telehealth, we serve every neighborhood in Medford, from the greater Medford area and the Rogue Valley of southern Oregon, without asking anyone to travel. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. From the coast to the high desert of Oregon, New Hope Weight Loss cares for patients by telehealth from our Costa Mesa, California clinic, so the same physician care reaches you anywhere in the state.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Medford telehealth visits.

How Telehealth Works for Medford

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Medford and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Medford door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Medford

Is there a New Hope Weight Loss clinic near Medford?

Our physical clinic is in Costa Mesa, California, and we care for patients in Medford, Oregon entirely by telehealth. You do not need a local office to start. Dr. Anjmun Sharma reviews your history and goals during a secure video consult, and your eligibility for a compounded GLP-1 program is confirmed there.

Do I have to travel to Costa Mesa from Medford for treatment?

No. Everything happens online, so Medford patients never drive to California. Your consult, follow-ups, and messaging run through a private portal. If you are approved, compounded semaglutide or tirzepatide ships straight to your Medford address in temperature-controlled cold-pack packaging to keep it stable in transit.

What does treatment cost for someone in Medford?

The physician review is $119. Compounded semaglutide starts at $166 a month, or $499 for the 90-day program, and tirzepatide starts at $233 a month. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, and there is no distance surcharge for Medford patients.

What areas of Medford do you serve?

We serve patients from across Medford by telehealth, including the greater Medford area and the Rogue Valley of southern Oregon.

Who qualifies for the program in Medford?

Eligibility for Medford patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Medford Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Medford, Oregon by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.